Featured Research

from universities, journals, and other organizations

Safeguards needed to prevent discrimination of early Alzheimer's patients in the workplace

Date:
September 20, 2011
Source:
University of Pennsylvania School of Medicine
Summary:
Despite the emergence of new tools that can diagnose Alzheimer's earlier, no effective interventions have been identified to stop the progression of the disease. A new report tackles the ethical and logistical challenges of safely and effectively communicating a diagnosis of pre-clinical Alzheimer's disease in light of the gulf between diagnosis and treatment.

The changing tide of Alzheimer's diagnosis presents new challenges to the public, physicians and lawmakers: if you could find out your Alzheimer's risk, would you want to know? How should doctors tell you your risk? And what does it mean for the many newly diagnosed Americans still in the workplace?

Despite the emergence of new tools that can diagnose Alzheimer's earlier, no effective interventions have been identified to stop the progression of the disease. A new report from the Perelman School of Medicine at the University of Pennsylvania tackles the ethical and logistical challenges of safely and effectively communicating a diagnosis of pre-clinical Alzheimer's disease in light of the gulf between diagnosis and treatment. The study appears in the October 11 print edition of Neurology.

Alzheimer's disease is among the most feared diseases of aging. The disease has been known for its role in memory loss and other clinical symptoms. But increasingly, patients learn they have the disease before symptoms start impacting their ability to function in daily life.

"We need to develop systems now, to navigate the challenges of a pre-clinical Alzheimer's diagnosis," said Jason Karlawish, MD, Professor of Medicine and Medical Ethics, author of the paper and leading voice on the ethics of Alzheimer's. "It's only a matter of time before we are able identify Alzheimer's before the patient is ill, like we've done with cholesterol and heart disease. Given the unique nature of this disease, which strips people of their independence as the disease progresses, safeguards are needed to protect those at high risk or with a pre-clinical diagnosis."

On the individual level, people strongly differ in their desire to know their risk and will react differently to a high Alzheimer's risk score or diagnosis in the early stages of the disease. In some cases, biomarker test results can be harmful; patients may develop anxiety or serious depression. To safely and effectively communicate a diagnosis of pre-clinical Alzheimer's disease, Dr. Karlawish recommends that researchers and clinicians track the emotional and physical impact of a pre-clinical diagnosis, then develop and disseminate best practices.

When an effective Alzheimer's therapy or intervention is found, a process will be necessary to ensure the patients who stand to benefit most are prioritized accordingly. Both prognostic and predictive evidence should be gauged against not only an individual's risk but the entire population at risk, especially if failure to intervene could cause large numbers of people to be impacted by any disease progression. A "National Alzheimer's Education Program" is proposed, to address how to translate research results into clinical practice for those with pre-clinical disease.

"The Alzheimer's disease label does not equate to disability," said Dr. Karlawish. In order to ensure that patients' daily lives (i.e. driving, financial planning, work status) aren't negatively or prematurely limited, laws and policies need to be revised to prevent stigma, discrimination and, when patients do suffer disability, exploitation.

"The discovery of pre-clinical Alzheimer's disease may be how we prevent the tsunami of Alzheimer's disease dementia, but we must not drown in the challenges created by our own discovery," warned Dr. Karlawish.

The study was sponsored by the Marian S. Ware Alzheimer Program and a Robert Wood Johnson Investigator Award in Health Policy Research.


Story Source:

The above story is based on materials provided by University of Pennsylvania School of Medicine. Note: Materials may be edited for content and length.


Journal Reference:

  1. J. Karlawish. Addressing the ethical, policy, and social challenges of preclinical Alzheimer disease. Neurology, 2011; DOI: 10.1212/WNL.0b013e318232ac1a

Cite This Page:

University of Pennsylvania School of Medicine. "Safeguards needed to prevent discrimination of early Alzheimer's patients in the workplace." ScienceDaily. ScienceDaily, 20 September 2011. <www.sciencedaily.com/releases/2011/09/110915171632.htm>.
University of Pennsylvania School of Medicine. (2011, September 20). Safeguards needed to prevent discrimination of early Alzheimer's patients in the workplace. ScienceDaily. Retrieved September 21, 2014 from www.sciencedaily.com/releases/2011/09/110915171632.htm
University of Pennsylvania School of Medicine. "Safeguards needed to prevent discrimination of early Alzheimer's patients in the workplace." ScienceDaily. www.sciencedaily.com/releases/2011/09/110915171632.htm (accessed September 21, 2014).

Share This



More Health & Medicine News

Sunday, September 21, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Sierra Leone in Lockdown to Control Ebola

Sierra Leone in Lockdown to Control Ebola

AP (Sep. 21, 2014) Sierra Leone residents remained in lockdown on Saturday as part of a massive effort to confine millions of people to their homes in a bid to stem the biggest Ebola outbreak in history. (Sept. 20) Video provided by AP
Powered by NewsLook.com
Sierra Leone's Nationwide Ebola Curfew Underway

Sierra Leone's Nationwide Ebola Curfew Underway

Newsy (Sep. 20, 2014) Sierra Leone is locked down as aid workers and volunteers look for new cases of Ebola. Video provided by Newsy
Powered by NewsLook.com
Changes Found In Brain After One Dose Of Antidepressants

Changes Found In Brain After One Dose Of Antidepressants

Newsy (Sep. 19, 2014) A study suggest antidepressants can kick in much sooner than previously thought. Video provided by Newsy
Powered by NewsLook.com
Could Grief Affect The Immune Systems Of Senior Citizens?

Could Grief Affect The Immune Systems Of Senior Citizens?

Newsy (Sep. 19, 2014) The study found elderly people are much more likely to become susceptible to infection than younger adults going though a similar situation. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins